Five-year outcome in the copaxone observatory: a nationwide cohort of patients with multiple sclerosis starting treatment with glatiramer acetate in France

The benefits provided by disease-modifying treatments in multiple sclerosis have been demonstrated in clinical trials, but the extent to which they can be extrapolated to everyday care is less clear, as are the long-term benefits of treatment. The objective of this prospective observational cohort s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebrun-Frenay, Christine, Moulignier, Antoine, Pierrot-Deseilligny, Charles, Benrabah, Rabah, Moreau, Thibault, Lubetzki, Catherine, Monchecourt, Françoise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420902/
https://www.ncbi.nlm.nih.gov/pubmed/30730008
http://dx.doi.org/10.1007/s00415-019-09211-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420902/
https://www.ncbi.nlm.nih.gov/pubmed/30730008
http://dx.doi.org/10.1007/s00415-019-09211-5

Ejemplares similares